Medical Footwear Market Size (2024 - 2029)

The medical footwear market is anticipated to experience growth driven by an increasing prevalence of foot-related issues and technological advancements in footwear design. The pandemic-induced sedentary lifestyle has exacerbated foot pain cases, thereby boosting demand for medical footwear. Partnerships among industry players are fostering the development of innovative products, further contributing to market expansion. Despite these positive trends, the high cost of medical footwear poses a challenge to market growth.

Market Size of Medical Footwear Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Medical Footwear Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR (2024 - 2029) 5.80 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Medical Footwear Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Medical Footwear Market Analysis

The Medical Footwear Market is expected to register a CAGR of 5.80% during the forecast period(2024-2029).

  • The COVID-19 pandemic had a negative impact on various industries, including the medical footwear market. Initially, manufacturing hubs worldwide faced challenges due to the pandemic's disruptions. However, the sedentary lifestyle adopted by many during the pandemic, characterized by limited physical activity, led to a notable increase in cases of foot pain. This surge in foot pain cases is projected to significantly influence the dynamics of the market.
  • For example, according to a report released by Central Massachusetts Podiatry in April 2022, there was a notable surge in patients seeking treatment for heel pain. When compared to data from the pre-pandemic year, the average annual increase in patients seeking heel pain treatment during the pandemic restrictions was approximately 30%, peaking at a remarkable 60% increase in 2021. Consequently, this upswing in cases of heel pain has led to a heightened demand for medical footwear throughout the pandemic period. This increased demand is anticipated to exert a substantial influence on the market's growth trajectory.
  • A key factor driving the market is the rising number of foot-related issues caused by poorly fitting shoes, such as plantar fasciitis, bunions, arthritis, foot and ankle injuries, corns, and flat feet. Additionally, technological advancements in medical footwear are also contributing to the growth of the market. According to the American Podiatric Medical Association (APMA) factsheet released in September 2021, 75% of Americans will, at some point in their lives, encounter foot health issues of varied degrees of severity. An annual average of 1.4-foot issues affect about 19% of United States citizens.
  • It also reported that each year, about 5% of the United States population has foot infections such as athlete's foot, other fungal infections, and warts. The longer these conditions are left untreated, the worse the pain and discomfort become for the people. This footwear offers cushioning to the entire foot, providing the wearer with the support to move freely. Hence, the increasing burden of foot health problems drives the growth of the studied market over the study period.
  • Furthermore, the new partnerships and agreements among the market players help in developing new medical footwear with new technologies. For instance, in December 2021, Sensoria Health and Darco International, Inc. signed a partnership to jointly develop smart diabetic footwear that is powered by mobile and cloud patient monitoring technology.
  • In addition, in June 2022, FootBalance and Run Mummy Run entered a community partnership with the aim of promoting the importance of foot health whilst creating educational and informative content for the members. These new partnerships help to expand the applications of medical footwear products and awareness of foot health, which is expected to drive the market over the study period.
  • However, the high cost of medical footwear likely impedes the growth of the market over the forecast period.

Medical Footwear Industry Segmentation

Medical footwear is those that are specifically designed to support or accommodate the mechanics and structure of the foot, ankle, and leg, and they have several medically beneficial features and functions that separate them from everyday footwear.

The medical footwear market is segmented by product (medical shoes & boots, medical sandals, and other products), end-user (men and women), distribution channel (offline and online), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.

The report offers the value (in USD) for the above segments.

By Product
Medical Shoes and Boots
Medical Sandals
Other Products (Slippers, Flip-flops, Insoles, etc.)
By End-User
Men
Women
By Distrubution Channels
Offline
Online
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Medical Footwear Market Size Summary

The medical footwear market is poised for growth, driven by an increasing prevalence of foot-related health issues and advancements in footwear technology. The market experienced initial setbacks due to the COVID-19 pandemic, which disrupted manufacturing and led to a rise in foot pain cases due to sedentary lifestyles. This surge in foot pain has heightened the demand for medical footwear, as these products offer essential support and cushioning for various foot conditions such as plantar fasciitis, bunions, and arthritis. The market is further bolstered by strategic partnerships and technological innovations, such as the development of smart diabetic footwear and community initiatives promoting foot health awareness. Despite the high cost of medical footwear posing a challenge, the growing awareness and need for foot care solutions continue to drive market expansion.

North America is expected to witness significant growth in the medical footwear market, fueled by an aging population and a rising incidence of diabetes and related foot conditions. The region's increasing awareness of foot care and the prevalence of diseases like arthritis further contribute to the demand for specialized footwear. Key market players are actively engaging in strategic collaborations and technological advancements, such as the introduction of pressure-mitigating footwear, to enhance product offerings and expand market reach. The competitive landscape is characterized by the presence of both international and local companies, with major players like Evonis (Dr. Comfort), Drewshoe, Incorporated, and Orthofeet Inc. leading the market. Recent innovations, such as health-tracking insoles and 3D-printed pressure-measuring insoles, highlight the ongoing advancements in the sector, promising to propel the market's growth trajectory in the coming years.

Explore More

Medical Footwear Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Foot-Related Issues and Growing Awareness about Foot-Related Concerns

      2. 1.2.2 Technological Advancement in Medical Footwear

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Medical Footwear

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value USD)

    1. 2.1 By Product

      1. 2.1.1 Medical Shoes and Boots

      2. 2.1.2 Medical Sandals

      3. 2.1.3 Other Products (Slippers, Flip-flops, Insoles, etc.)

    2. 2.2 By End-User

      1. 2.2.1 Men

      2. 2.2.2 Women

    3. 2.3 By Distrubution Channels

      1. 2.3.1 Offline

      2. 2.3.2 Online

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Medical Footwear Market Size FAQs

The Medical Footwear Market is projected to register a CAGR of 5.80% during the forecast period (2024-2029)

Drewshoe, Incorporated, Orthofeet Inc., Enovis (Dr. Comfort), DARCO International, Inc. and Clearwell Mobility Ltd are the major companies operating in the Medical Footwear Market.

Medical Footwear Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)